Read the latest news from Health. Watch out for current health warnings. And find out how you can have your say on issues that affect you.
Australia's National Immunisation Strategy for 2019 to 2024 has now been released. The strategy includes eight strategic priority areas for action to complement and strengthen the NIP.
The human papillomavirus (HPV) vaccine is available for free to young Australians through the National Immunisation Program (NIP).
Phase 3 of the Childhood Immunisation Education Campaign – Get the Facts (the Campaign) has launched to encourage Australian parents and carers to get their kids vaccinated.
The Australian Government is extending childhood immunisation arrangements for family assistance payments to increase immunisation rates of children residing in Australia.
A public consultation is currently open on proposed changes to the recommended use of pertussis vaccines in pregnant women in the Australian Immunisation Handbook.
AusVaxSafety is a national system for monitoring vaccine safety in Australia. The report shows how parents and carers responded to the SMS about their child's health a few days after their vaccination at each schedule point in the National Immunisation Program (NIP) in Australia in 2016-17.
The Australian Institute of Health and Welfare has recently published a series of Fact Sheets on vaccine preventable diseases. They provide information about the diseases and their impact in Australia, including the number of cases reported, hospitalisations and deaths.
Human papillomavirus (HPV) vaccinations are now recorded on the Australian Immunisation Register (AIR). This makes it easier for you and your healthcare provider to find information about your or your child’s HPV vaccinations.
Human papillomavirus (HPV) vaccine doses can now be recorded on the Australian Immunisation Register (AIR). This makes it easier for healthcare providers to find information about their patient’s HPV vaccinations.
The Australian Government will invest $52 million to protect Australian teenagers against meningococcal through a free national program for 14 to 19 year olds.
The Pertussis Chapter, 4.12, of the 10th Edition of the Australian Immunisation Handbook has been updated and includes two changes to recommendations in the administration of pertussis-containing vaccine.
The shingles vaccine, Zostavax®, has been approved to be placed on the National Immunisation Program (NIP), to be provided free of charge from 1 November 2016 to people aged 70 years. There will also be a 5 year catch-up program for people aged 71 to 79 years.
Meningococcal B vaccine and clinical advice for immunisation providers regarding the use of Bexsero® (4CMenB). From 5 March 2014, the recombinant multicomponent meningococcal B vaccine Bexsero® (4CMenB) became available through purchase on the private market.
The Australian Technical Advisory Group on Immunisation is consulting with stakeholders on proposed changes to meningococcal and Haemophilus influenzae type B vaccination recommendations for inclusion in the Australian Immunisation Handbook.
Advice on the presence of natural rubber latex in the sheath covering the needle of the Fluad trivalent influenza vaccine. Anyone who has a severe allergy to latex should not receive Fluad.
The Zostavax® vaccine is now available nationally for immunisation providers for people aged 70 to 79 years under the National Immunisation Program (NIP).
The Australian Technical Advisory Group on Immunisation (ATAGI) has provided advice regarding alternatives during supply shortage of the adult formulations of hepatitis B vaccines.